Table 1 Clinical correlation analysis of LncRNA TTN-AS1 expression in serum extracellular vesicles of patients with cholangiocarcinoma
Features | Number | Mean ± SD | P value | Significance |
|---|---|---|---|---|
Gender | ||||
Male | 19 | -5.34 ± 1.95 | 0.684 | |
Female | 13 | -4.64 ± 2.34 | ||
Age (years) | ||||
< 60 | 20 | -4.94 ± 2.81 | 0.314 | |
≥ 60 | 12 | -5.34 ± 1.96 | ||
Tumor size | ||||
< 5 cm | 17 | -5.64 ± 2.84 | 0.297 | |
≥ 5 cm | 15 | -4.71 ± 3.41 | ||
Metastasis | ||||
Negative | 12 | -5.13 ± 2.64 | 0.005 | ** |
Positive | 20 | -6.71 ± 1.18 | ||
Tumor differentiation | ||||
Well/moderate | 18 | -5.84 ± 2.14 | 0.378 | |
Poor | 14 | -5.17 ± 1.98 | ||
Portal vein invasion | ||||
No | 15 | -5.67 ± 1.94 | 0.648 | |
Yes | 17 | -4.84 ± 2.38 | ||
Tumor location | ||||
Intrahepatic | 10 | -5.84 ± 2.67 | 0.651 | |
Perihilar | 22 | -4.25 ± 1.49 | ||
TNM stage | ||||
I/II | 15 | -4.75 ± 2.19 | 0.003 | ** |
III / IV | 17 | -6.18 ± 1.67 |